TY - JOUR
T1 - Epilepsy and electroencephalogram evolution in YWHAG gene mutation
T2 - A new phenotype and review of the literature
AU - Stern, Tomer
AU - Orenstein, Naama
AU - Fellner, Avi
AU - Lev-El Halabi, Noa
AU - Shuldiner, Alan R.
AU - Gonzaga-Jauregui, Claudia
AU - Lidzbarsky, Gabriel
AU - Basel-Salmon, Lina
AU - Goldberg-Stern, Hadassa
N1 - Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/3
Y1 - 2021/3
N2 - A male patient with a de novo mutation in the YWHAG gene and mild phenotype is presented. He had normal delivery and normal development, with normal speech and social milestones. At the age of 9 months, myoclonic seizures started, with generalized epileptiform discharges. The child responded well to levetiracetam monotherapy with complete seizure resolution. Levetiracetam was stopped and he remained seizure-free for 10 months. His development was appropriate for age according to psychological evaluation and he attended a regular kindergarten. At the age of approximately 4 years, the seizures reappeared with different semiology of staring with eye blinking. Electroencephalogram (EEG) showed multifocal spikes. Brain magnetic resonance imaging did not reveal any structural abnormality. Genetic analysis revealed a de novo likely pathogenic missense variant in the YWHAG gene (c.619G>A p.Glu207Lys). We compared our case to the other cases published in the literature. Our case is unique in its seizure semiology and evolution of EEG. Moreover, in contrast to our case, the majority of cases described in the literature have dysmorphism and intellectual disability or autistic spectrum disorder. This report emphasizes the phenotypic heterogeneity of YWHAG mutation as is the case in other developmental encephalopathies.
AB - A male patient with a de novo mutation in the YWHAG gene and mild phenotype is presented. He had normal delivery and normal development, with normal speech and social milestones. At the age of 9 months, myoclonic seizures started, with generalized epileptiform discharges. The child responded well to levetiracetam monotherapy with complete seizure resolution. Levetiracetam was stopped and he remained seizure-free for 10 months. His development was appropriate for age according to psychological evaluation and he attended a regular kindergarten. At the age of approximately 4 years, the seizures reappeared with different semiology of staring with eye blinking. Electroencephalogram (EEG) showed multifocal spikes. Brain magnetic resonance imaging did not reveal any structural abnormality. Genetic analysis revealed a de novo likely pathogenic missense variant in the YWHAG gene (c.619G>A p.Glu207Lys). We compared our case to the other cases published in the literature. Our case is unique in its seizure semiology and evolution of EEG. Moreover, in contrast to our case, the majority of cases described in the literature have dysmorphism and intellectual disability or autistic spectrum disorder. This report emphasizes the phenotypic heterogeneity of YWHAG mutation as is the case in other developmental encephalopathies.
KW - YWHAG mutation
KW - developmental and epileptic encephalopathy
KW - early onset myoclonic seizures
KW - phenotypic heterogenity
UR - http://www.scopus.com/inward/record.url?scp=85099026080&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.62026
DO - 10.1002/ajmg.a.62026
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33393734
AN - SCOPUS:85099026080
SN - 1552-4825
VL - 185
SP - 901
EP - 908
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 3
ER -